Member Info for Dibs61

Complete collapse in market confidence. Let’s be clear there will be no magical ginormous up front payments deal. Not within the timeframe required here anyway. They have less than two months. A placing takes time to arrange let alone a deal to buy one of their products!

The narrative within the market has switched overnight. It’s no longer about PSE/CIRT test sales. It’s now all about the cash position. This is what the market will now obsess about until it is resolved OR there is a booming announcement which flips the switch again. I personally think the latter is unlikely but not impossible they could pull a rabbit out the hat.

No, it’s all going to be about how much cash they need and what price will they get. With the current Cashburn at somewhere between £800k to £850k pm they really want a minimum 12 month runway which means £10m minimum. With the price already at 25p that tells you the market thinks it’s not going to be more than 25p. My guess would be 20p. Due to the disappointing test sales they will NOT get a premium. Investors will drive a harder bargain in this market.

Dug - haha I got ‘lucky’ errrr no luck involved I just knew how to interpret a poorly written RNS and tbh it wasn’t that hard really.

So ironic you should call me ‘infantile’. Check back my posts, nothing remotely childish and even now, I don’t feel the need to get personal apart from recognising the irony ;). Oh and I never asked for an apology I simply said a bigger man admits when he gets it wrong. Starting to see a pattern in your ability to interpret what you read.

Bonker thx for reply. I see you on X posting about BKY. I share your bullish view notwithstanding the permitting issues.

What do you make of these after hours trades again today at a premium? Same thing happened yesterday.

Dug,

I’m not ‘singling’ you out. I’m simply pointing out the facts (which I did this morning) and you were adamant you were correct. You don’t have to admit you were wrong but given the fuss you made about it and the confusion it caused a bigger man would admit they were wrong.

As for my investments I think we are ALL substantially down today no? I confirmed earlier I’m still holding but that has never stopped me from ripping into management when it’s justified and boy it is justified here.

My next point…. In the RNS we were told that the absence of ONE sales rep during the summer was responsible for the ahem derailing of CIRT Test sales growth. On its own this seems crazy. How could this happen in plain sight of management! Answer : they were probably all on vacation at the time too….

But wait, hang on, were we not informed earlier this year that the pillar of their sales strategy was P2P, and for those that don’t know what that means, it means peer to peer or, in OBD’s case - Doctor to Doctor. All these clinical advisory board meetings were going to result in doctors selling to other doctors who would then sell to other doctors. Great eh!?

That was surely the whole point of P2P, that it negated the need for an active sales personnel team. Do they not understand how absurd it then sounds when they say the failure of sales growth was down to leave of absence of one individual.

But that’s not all, Back in the May presentation, or even in the November presentation there was absolutely NO mention that CIRT sales were expected to tail off in the summer months.

Yet today in the RNS we were told it was always ‘expected’.

Do they take us for fools, imbeciles? I actually listen to everything they say. I also read the RNS’s meticulously (unlike a few on here)

I find this kind of thing insulting and arrogant and quite disingenuous.

The rest of you are free to Lao up their BS but I would warn you to be cautious in future of anything they say.

By the way, and this is for Dug who has gone very quiet, Jon Burrows confirmed they have sold 770 tests (or whatever the figure was exactly) in TOTALITY. Even he says that has been put to bed so he obviously read the ridiculous hysteria about it this morning on the BB. AIM Execs do often look at these boards you know!

Unlike many here I am not impressed. There are a number of points that are highly debatable and one or two things that imho quite disingenuous.

As I said earlier for me personally trust in management is key. Up until this morning I had no reason to doubt management. But boy oh boy today has been an eye opener.

For example there was a suggestion, no, a clear indication that OBD were approached by not one but several ‘third parties’ regarding two of the tests in their pipeline that coincidentally just happen to be open ready. How convenient. How timely. I don’t believe it. No OBD have put the feelers out NOT the other way around. This is very different to actually being approached.

We haven’t even seen the documented validation of these tests yet Mr Burrows is claiming he’s been told by these ‘third parties’ that their colorectal test is the best on the market?? How the hell did they reach that conclusion?

I’ve plenty more to say but I’ll leave it for now…

Stated EARLY discussions. So they haven’t been talking for some time. These deals take tim. Period. Lots to thrash out. Legals etc

Cut through the BS

100% placing coming

Krull - hi there ref the potential deals The problem is Time is not on their side. I would guesstimate they have no more than two months, possibly less to complete these deals and they take time.

I think it far more likely they are going to have to go to the market for more cash, and they are not in a strong position to do so. Today’s news has bought any share price advance to a juddering halt. I see this struggling until the cash position is resolved and it is clear that growth in test sales has resumed. There is considerable uncertainty over both these issues.

Long-term the potential remains considerable but short term looks rocky.

I am wondering about how Big Pharma feel about little OBD negatively impacting some of their lucrative ICI drug sales with a test that ‘outs’ their efficacy (or lack of). Let’s not forget they will have a cosy relationship (through THEIR sales people) with many of the oncologists we are hoping to persuade to use our test.

Let’s put this another way, would the SP be 26p and down 21% if they had sold 770 CIRT Tests since 1st October.

I can see why this could be misinterpreted because I don’t think the company were clear enough in the way they provided the stats. Perhaps deliberately who knows?

But I am in no doubt whatsoever that they have NOT sold 770 tests since 1st October. Do you not think Jon Burrows would’ve been far more upbeat in his statement had they done so?

One other thing I’m rather peeved about. In the November 2023 presentation- NOVEMBER - the company provided CIRT test sales figures only to the end of June. Now we know why!?

Because the sales growth dropped right off afterwards! You can’t tell me they didn’t have the July to October figures when they put that presentation together.

Trust is very important to me as an investor so Mr Burrows has some explaining to do.

Hi Newuncle ‘So that 144 PSE tests in the USA since 1 Jan 2024.......’

No I do not believe that is correct . It’s 144 tests sold in total since launch in Sept in both the US AND the UK. Check the RNS it’s all there.

Just trying to be factual. I want this to succeed as much as you!

I was shocked and surprised by the CIRT numbers this morning I have to say.

That said the SP always tells you a story and the SP was telling us.

It’s absolutely clear they will need a fundraising and soon.

Fantastic potential and I will hold but this is quite a setback actually.

It is truly p*sing in the wind the idea of ‘director buys’ here. You think Newland is going to give up a single penny of his obscenely overpaid salary? Now that WOULD be ‘groundbreaking’ if it ever happened! I think you need to try working another ‘Angle’ carrots!

Yes we’ve had a single seller today unloading at 30k blocks which has halted this mornings advance as we lost the buying pressure from earlier.

All very academic though as all eyes turn to tomorrow. Seem to have been waiting forever for this announcement!

Bonker are you the £1285 buyer today?

Steady downward trend on intraday chart. Finish around the low of the day.

Stock massively overvalued with no coherent commercial strategy from clueless management who rely on hyperbole and confusing communication to market.

I suspect we have a few momentum traders who bought in on the recent pre results rally but had no intention of being in for the results - selling out today. The sell before news brigade if you like….

Yep 36p def a technical resistance point so if we break that level looking v good.

It’s more when rather than if isn’t it.